$6.89
-0.09-1.29%
At Close: -
$7.00
0.111.60%
After Hours: Sep 20, 9:27 AM EDT
15 minutes delayed
Purple Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Purple Biotech using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-16 | $-1.80 | $-3.60 | 50.0 % |
Mar 2024 | 2024-05-21 | $-2.80 | $-3.80 | 26.3 % |
Dec 2023 | 2024-03-05 | $-3.80 | $-3.80 | 0.00 % |
Sep 2023 | 2023-11-21 | $-4.60 | $-4.60 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Purple Biotech (PPBT) is scheduled to report earnings on November 19, 2024. The last reported earnings were for reported on August 16, 2024 for Q2.
The Actual EPS was $-1.80, which beat the estimate of $-3.60.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.